Table 2.
Group | Phase | Heart rate (Times/min) | Respiratory rate (Times/min) | Dosage of NE (μg·kg·min) |
---|---|---|---|---|
Observation group (n=23) | Before treatment | 113.62±18.95 | 25.84±3.94 | 1.09±0.57 |
After treatment | 76.48±10.13* | 16.58±2.79* | 0.38±0.23* | |
t | 9.177 | 10.018 | 6.209 | |
P | 0.000 | 0.000 | 0.000 | |
Control group (n=30) | Before treatment | 115.02±19.27 | 25.18±3.75 | 1.17±0.42 |
After treatment | 85.62±10.85 | 19.27±2.66 | 0.61±0.32 | |
t | 7.282 | 7.041 | 5.809 | |
P | 0.000 | 0.000 | 0.000 |
P<0.05 compared with before treatment.